TrendingVideosIndia
Opinions | CommentEditorialsThe MiddleLetters to the EditorReflections
Sports
State | Himachal PradeshPunjabJammu & KashmirHaryanaChhattisgarhMadhya PradeshRajasthanUttarakhandUttar Pradesh
City | ChandigarhAmritsarJalandharLudhianaDelhiPatialaBathindaShaharnama
World | United StatesPakistan
Diaspora
Features | Time CapsuleSpectrumIn-DepthTravelFood
EntertainmentIPL 2025
Business | My MoneyAutoZone
UPSC | Exam ScheduleExam Mentor
Advertisement

‘30% Covaxin takers reported adverse events’

New Delhi, May 16 Nearly one-third of 926 individuals who received Bharat Biotech’s anti-Covid vaccine Covaxin reported ‘adverse events of special interest,’ or AESI, according to a one-year follow up study conducted by a team of researchers at BHU. Serious...
Advertisement

New Delhi, May 16

Nearly one-third of 926 individuals who received Bharat Biotech’s anti-Covid vaccine Covaxin reported ‘adverse events of special interest,’ or AESI, according to a one-year follow up study conducted by a team of researchers at BHU.

Advertisement

Serious AESI, which included stroke and Guillain-Barre syndrome, were reported in one per cent of individuals, the study conducted by researchers from the Banaras Hindu University (BHU).

Advertisement
Tags :
Bharat
Show comments
Advertisement